P-glycoprotein at the blood-brain barrier and analysis of drug transport with positron-emission tomography

被引：0
|
作者：
Hendrikse, NH
Bart, J
de Vries, EGE
Groen, HJM
van der Graaf, WTA
Vaalburg, W
机构：
[1] Univ Groningen Hosp, PET Ctr, NL-9700 RB Groningen, Netherlands
[2] Univ Groningen Hosp, Dept Med Oncol, Groningen, Netherlands
[3] Univ Groningen Hosp, Dept Pulm Dis, Groningen, Netherlands
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 2001年
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：48S / 54S
页数：7
相关论文
共 50 条
  • [1] Imaging P-glycoprotein transport activity at the human blood-brain barrier with positron emission tomography
    Sasongko, L
    Link, JM
    Muzi, M
    Mankoff, DA
    Yang, XD
    Collier, AC
    Shoner, SC
    Unadkat, JD
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (06) : 503 - 514
  • [2] Species Differences in Blood-Brain Barrier Transport of Three Positron Emission Tomography Radioligands with Emphasis on P-Glycoprotein Transport
    Syvanen, Stina
    Lindhe, Orjan
    Palner, Mikael
    Kornum, Birgitte R.
    Rahman, Obaidur
    Langstrom, Bengt
    Knudsen, Gitte M.
    Hammarlund-Udenaes, Margareta
    DRUG METABOLISM AND DISPOSITION, 2009, 37 (03) : 635 - 643
  • [3] Kinetic Models for Measuring P-glycoprotein Function at the Blood-Brain Barrier with Positron Emission Tomography
    Lubberink, Mark
    CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (38) : 5786 - 5792
  • [4] Factors That Limit Positron Emission Tomography Imaging of P-Glycoprotein Density at the Blood-Brain Barrier
    Kannan, Pavitra
    Pike, Victor W.
    Halldin, Christer
    Langer, Oliver
    Gottesman, Michael M.
    Innis, Robert B.
    Hall, Matthew D.
    MOLECULAR PHARMACEUTICS, 2013, 10 (06) : 2222 - 2229
  • [5] Regional P-Glycoprotein Activity and Inhibition at the Human Blood-Brain Barrier as Imaged by Positron Emission Tomography
    Eyal, S.
    Ke, B.
    Muzi, M.
    Link, J. M.
    Mankoff, D. A.
    Collier, A. C.
    Unadkat, J. D.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 (05) : 579 - 585
  • [6] Interaction of HM30181 with P-glycoprotein at the murine blood-brain barrier assessed with positron emission tomography
    Bauer, Florian
    Wanek, Thomas
    Mairinger, Severin
    Stanek, Johann
    Sauberer, Michael
    Kuntner, Claudia
    Parveen, Zahida
    Chiba, Peter
    Mueller, Markus
    Langer, Oliver
    Erker, Thomas
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2012, 696 (1-3) : 18 - 27
  • [7] Complete in vivo reversal of P-glycoprotein pump function in the blood-brain barrier visualized with positron emission tomography
    Hendrikse, NH
    Schinkel, AH
    De Vries, EGE
    Fluks, E
    Van der Graaf, WTA
    Willemsen, ATM
    Vaalburg, W
    Franssen, EJF
    BRITISH JOURNAL OF PHARMACOLOGY, 1998, 124 (07) : 1413 - 1418
  • [8] P-GLYCOPROTEIN MEDIATED DRUG-DRUG INTERACTION AT THE HUMAN BLOOD-BRAIN BARRIER STUDIED WITH POSITRON EMISSION TOMOGRAPHY, A COMPARISON WITH RAT DATA
    Bauer, M.
    Zeitlinger, M.
    Karch, R.
    Matzneller, P.
    Mueller, M.
    Langer, O.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 72 : 25 - 25
  • [9] The antiepileptic drug mephobarbital is not transported by P-glycoprotein or multidrug resistance protein 1 at the blood-brain barrier: A positron emission tomography study
    Mairinger, Severin
    Bankstahl, Jens P.
    Kuntner, Claudia
    Roemermannd, Kerstin
    Bankstahl, Marion
    Wanek, Thomas
    Stanek, Johann
    Loescher, Wolfgang
    Muellner, Markus
    Erker, Thomas
    Langer, Oliver
    EPILEPSY RESEARCH, 2012, 100 (1-2) : 93 - 103
  • [10] P-glycoprotein regulated transport of glutamate at blood-brain barrier
    Liu, XD
    Liu, GQ
    ACTA PHARMACOLOGICA SINICA, 2001, 22 (02): : 111 - 116
12345